Interleukin-35 Enhances Regulatory T Cell Function by Potentially Suppressing Their Transdifferentiation into a T Helper 17-Like Phenotype in Kawasaki Disease

References

• Agarwal S, Agrawal DK. 2017. Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol. 13(3):247–58.
   PubMed Web of Science ®Google Scholar
• Cho J, Kim S, Yang DH, Lee J, Park KW, Go J, Hyun CL, Jee Y, Kang KS. 2018. Mucosal immunity related to FOXP3 + regulatory T cells, Th17 cells and cytokines in pediatric inflammatory Bowel disease. J Korean Med Sci. 33(52):e336.
   PubMed Web of Science ®Google Scholar
• Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, et al. 2012. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol. 13(3):290–99.
   PubMed Web of Science ®Google Scholar
• Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 450(7169):566–69.
   PubMed Web of Science ®Google Scholar
• Diller ML, Kudchadkar RR, Delman KA, Lawson DH, Ford ML. 2016. Balancing inflammation: the link between Th17 and regulatory T cells. Mediators Inflamm. 2016:6309219. doi:10.1155/2016/6309219.
   PubMed Web of Science ®Google Scholar
• Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S. 2010. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 30(1):80–89.
   PubMed Web of Science ®Google Scholar
• Franco A, Shimizu C, Tremoulet AH, Burns JC. 2010. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity. 43(4):317–24.
   PubMed Web of Science ®Google Scholar
• Franco A, Touma R, Song Y, Shimizu C, Tremoulet AH, Kanegaye JT, Burns JC. 2014. Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity. 47(2):95–104.
   PubMed Web of Science ®Google Scholar
• Furuno K, Yuge T, Kusuhara K, Takada H, Nishio H, Khajoee V, Ohno T, Hara T. 2004. CD25+CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr. 145(3):385–90.
   PubMed Web of Science ®Google Scholar
• Gagliani N, Amezcua Vesely MC, Iseppon A, Brockmann L, Xu H, Palm NW, de Zoete MR, Licona-Limon P, Paiva RS, Ching T, et al. 2015. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature. 523(7559):221–25.
   PubMed Web of Science ®Google Scholar
• Gunduz E, Sermet S, Musmul A. 2016. Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients. Cytometry B Clin Cytom. 90(5):449–54.
   PubMed Web of Science ®Google Scholar
• Guo J, Gu M, Zhang W, Liu Y, Qian C, Deng A. 2018. Aberrant IL-35 levels in patients with primary Sjogren’s syndrome. Scand J Immunol. 88(5):e12718.
   PubMed Web of Science ®Google Scholar
• Guo MM, Tseng WN, Ko CH, Pan HM, Hsieh KS, Kuo HC. 2015. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy. 70(3):310–18.
   PubMed Web of Science ®Google Scholar
• He W, Hao S, Dong X, Zhang D, Jia Z. 2022. Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus. Bosn J Basic Med Sci. doi:10.17305/bjbms.2022.7525
   Google Scholar
• Huang Q, Wang Y, Si C, Zhao D, Wang Y, Duan Y. 2017. Interleukin-35 modulates the imbalance between regulatory T cells and T helper 17 cells in enterovirus 71-induced hand, foot, and mouth disease. J Interferon Cytokine Res. 37(12):522–30.
   PubMed Web of Science ®Google Scholar
• Jia S, Li C, Wang G, Yang J, Zu Y. 2010. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol. 162(1):131–37.
   PubMed Web of Science ®Google Scholar
• Koizumi K, Hoshiai M, Moriguchi T, Katsumata N, Toda T, Kise H, Hasebe Y, Kono Y, Sunaga Y, Yoshizawa M, et al. 2019. Plasma exchange downregulates activated monocytes and restores regulatory T cells in Kawasaki disease. Ther Apher Dial. 23(1):92–98.
   PubMed Web of Science ®Google Scholar
• Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-Hora M, Kodama T, Tanaka S, Bluestone JA, Takayanagi H. 2014. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 20(1):62–68.
   PubMed Web of Science ®Google Scholar
• Lee GR. 2018. The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci. 19(3):730.
   PubMed Web of Science ®Google Scholar
• Liao HT, Lin YF, Tsai CY, Chou CT. 2015. Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment. Joint Bone Spine. 82(6):423–27.
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang Q, Shao X, Wang W, Zhang C, Jin Z. 2017. An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection. Int Immunopharmacol. 50:87–94.
   PubMed Web of Science ®Google Scholar
• Liu ZZ, Sun GQ, Hu XH, Kwak-Kim J, Liao AH. 2017. The transdifferentiation of regulatory T and Th17 cells in autoimmune/inflammatory diseases and its potential implications in pregnancy complications. Am J Reprod Immunol. 78(2):e12657.
   Web of Science ®Google Scholar
• Ma Y, Chen L, Xie G, Zhou Y, Yue C, Yuan X, Zheng Y, Wang W, Deng L, Shen L. 2016. Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3. Oncotarget. 7(45):73003–15.
   PubMedGoogle Scholar
• Matsubara T, Ichiyama T, Furukawa S. 2005. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol. 141(3):381–87.
   PubMed Web of Science ®Google Scholar
• McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, et al. 2017. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 135:e927–99. doi:10.1161/CIR.0000000000000484.
   PubMed Web of Science ®Google Scholar
• Miyara M, Sakaguchi S. 2007. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med. 13(3):108–16.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Saito K, Kumagai J, Nakajima Y, Kijima T, Yoshida S, Kihara K, Fujii Y. 2018. Higher serum C-reactive protein level represents the immunosuppressive tumor microenvironment in patients with clear cell renal cell carcinoma. Clin Genitourin Cancer. 16(6):e1151–58.
   PubMed Web of Science ®Google Scholar
• Niedbala W, Wei X-Q, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol. 37(11):3021–29.
   PubMed Web of Science ®Google Scholar
• Nyirenda MH, Sanvito L, Darlington PJ, O’Brien K, Zhang GX, Constantinescu CS, Bar-Or A, Gran B. 2011. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J Immunol. 187(5):2278–90.
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Wajda A, Romanowska-Prochnicka K, Walczuk E, Kuca-Warnawin E, Kmiolek T, Stypinska B, Rzeszotarska E, Majewski D, Jagodzinski PP, et al. 2020. Th17/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis. Front Immunol. 11:572858. doi:10.3389/fimmu.2020.572858.
   PubMed Web of Science ®Google Scholar
• Rasouli M, Heidari B, Kalani M. 2014. Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease. Immunol Lett. 162(1):269–75.
   PubMed Web of Science ®Google Scholar
• Rife E, Gedalia A. 2020. Kawasaki disease: an update. Curr Rheumatol Rep. 22(10):75.
   PubMed Web of Science ®Google Scholar
• Shao Y, Yang WY, Saaoud F, Drummer C, Sun Y, Xu K, Lu Y, Shan H, Shevach EM, Jiang X, et al. 2021. IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms. JCI Insight. 6(19):e152511.
   PubMed Web of Science ®Google Scholar
• Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D. 2009. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Clin Immunol. 131(1):109–18.
   PubMed Web of Science ®Google Scholar
• Singh S, Jindal AK, Pilania RK. 2018. Diagnosis of Kawasaki disease. Int J Rheum Dis. 21(1):36–44.
   PubMed Web of Science ®Google Scholar
• Su Y, Feng S, Luo L, Liu R, Yi Q. 2019. Association between IL-35 and coronary arterial lesions in children with Kawasaki disease. Clin Exp Med. 19(1):87–92.
   PubMed Web of Science ®Google Scholar
• Sun M, Xing H. 2021. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease. Int Immunopharmacol. 96:107642. doi:10.1016/j.intimp.2021.107642.
   PubMed Web of Science ®Google Scholar
• Teymouri M, Pirro M, Fallarino F, Gargaro M, Sahebkar A. 2018. IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases. Int J Cancer. 143(9):2105–15.
   PubMed Web of Science ®Google Scholar
• Wang D, Lei L. 2021. Interleukin-35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases. Int J Rheum Dis. 24:21–27. doi:10.1111/1756-185X.13962.
   PubMed Web of Science ®Google Scholar
• Xing H, Tian G. 2020. Increased interleukin-35 suppresses peripheral CD14(+) monocytes function in patients with Kawasaki disease. BMC Immunol. 21(1):17.
   PubMed Web of Science ®Google Scholar
• Yang L, Jia S, Shao X, Liu S, Zhang Q, Song J, Wang W, Jin Z. 2019. Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection. Virol J. 16(1):48.
   PubMedGoogle Scholar
• Ye C, Yano H, Workman CJ, Vignali DAA. 2021. Interleukin-35: structure, function and its impact on immune-related diseases. J Interferon Cytokine Res. 41(11):391–406.
   PubMed Web of Science ®Google Scholar
• Yu N, Li X, Song W, Li D, Yu D, Zeng X, Li M, Leng X, Li X. 2012. CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood. Inflammation. 35(6):1773–80.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lian JQ, Huang CX, Wang JP, Wei X, Nan XP, Yu HT, Jiang LL, Wang XQ, Zhuang Y, et al. 2010. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection. Virology. 397(1):34–42.
   PubMed Web of Science ®Google Scholar